Show simple item record

dc.contributor.authorPascual-Gamarra, Jose M
dc.contributor.authorSalazar-Tortosa, Diego F
dc.contributor.authorLabayen, Idoia
dc.contributor.authorRupérez, Azahara I
dc.contributor.authorLeclercq, Catherine
dc.contributor.authorMarcos, Ascension
dc.contributor.authorGómez, Sonia
dc.contributor.authorMoreno, Luis A
dc.contributor.authorMeirhaeghe, Aline
dc.contributor.authorCastillo, Manuel J
dc.contributor.authorR Ruiz, Jonatan
dc.date.accessioned2020-02-13T00:12:20Z
dc.date.available2020-02-13T00:12:20Z
dc.date.issued2020-01-03
dc.identifier.citationPascual-Gamarra, J.M., Salazar-Tortosa, D.F., Labayen, I. et al. Association of UCP1, UCP2 and UCP3 gene polymorphisms with cardiovascular disease risk factors in European adolescents: the HELENA study. Pediatr Res (2020). https://doi.org/10.1038/s41390-019-0735-7en_US
dc.identifier.issn0031-3998
dc.identifier.pmid31899915
dc.identifier.doi10.1038/s41390-019-0735-7
dc.identifier.urihttp://hdl.handle.net/10150/637011
dc.description.abstractBackground Cardiovascular diseases (CVDs) are responsible for 31% of all deaths worldwide. Genetic predisposition to CVDs in adolescents remains largely unknown. The aim of this study was to examine the association of UCP1, UCP2 and UCP3 gene polymorphisms with CVD risk factors in European adolescents. Method A cross-sectional study that involves 1.057 European adolescents (12-18 years old) from the HELENA study. A total of 18 polymorphisms of UCP1, UCP2 and UCP3 genes were genotyped. We measured serum total cholesterol, high-density lipoprotein,low-density lipoprotein, ApoA1, ApoB, leptin, triglycerides, glucose, insulin and blood pressure, and calculated HOMA (homeostatic model assessment), Quantitative Insulin Sensitivity Check Index (QUICKI) and a CVD risk score. Results The G allele of UCP2 rs2735572 and T allele of UCP2 rs17132534 were associated with higher diastolic blood pressure (P = 0.001; false discovery rate [FDR] = 0.009 and P = 8e-04; FDR = 0.009, respectively). We observed that the AATAG haplotype of UCP1 was associated with higher serum ApoB/ApoA1 (P = 0.008; FDR = 0.031) and ApoB levels (P = 0.008; FDR = 0.031). Moreover, the ACC haplotype of UCP3 was associated with a higher CVD risk score (P = 0.0036; FDR = 0.01). Conclusions Two UCP2 polymorphisms and haplotypes of UCP1 and UCP3 were associated with CVD risk factors. These findings suggest that UCPs may have a role in the development of CVD already in adolescents.en_US
dc.language.isoenen_US
dc.publisherNATURE PUBLISHING GROUPen_US
dc.rightsCopyright © International Pediatric Research Foundation, Inc. 2020en_US
dc.titleAssociation of UCP1, UCP2 and UCP3 gene polymorphisms with cardiovascular disease risk factors in European adolescents: the HELENA studyen_US
dc.typeArticleen_US
dc.contributor.departmentUniv Arizona, Dept Ecol & Evolutionary Biolen_US
dc.identifier.journalPEDIATRIC RESEARCHen_US
dc.description.note6 month embargo; published online: 3 January 2020en_US
dc.description.collectioninformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.en_US
dc.eprint.versionFinal accepted manuscripten_US
dc.source.journaltitlePediatric research
dc.source.countryUnited States


Files in this item

Thumbnail
Name:
salazar_etal_2020.pdf
Embargo:
2020-07-03
Size:
808.9Kb
Format:
PDF
Description:
Final Accepted Manuscript

This item appears in the following Collection(s)

Show simple item record